# US 2021/0341753 A1 · Method and Apparatus for Limiting Growth of Eye Length

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0341753 A1
- Document ID: US20210341753A1
- Status: Published application
- Kind: A1
- Application number: 17/352,570
- Filed: 2021-06-21
- Published: 2021-11-04
- Earliest claimed: 2008-12-22
- Assignees: The Medical College of Wisconsin, Inc.
- Applicants: The Medical College of Wisconsin, Inc.
- Inventors: Jay Neitz; Maureen Neitz
- Web page: https://patentgrep.com/patent/US20210341753A1

## CPC

- G02C 7/04: Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00)
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61P 27/02: Ophthalmic agents
- A61P 27/10: for accommodation disorders, e.g. myopia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- G02C 7/02: Lenses; Lens systems {; Methods of designing lenses}
- G02C 7/022: {Ophthalmic lenses having special refractive features achieved by special materials or material structures (G02C7/049 takes precedence)}
- G02C 7/061: {Spectacle lenses with progressively varying focal power}
- G02C 7/10: Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
- G02C 7/16: Shades; shields; Obturators, e.g. with pinhole, with slot {(G02C5/003 takes precedence)}
- A61B 3/1005: {for measuring distances inside the eye, e.g. thickness of the cornea (A61B3/11 takes precedence)}
- A61B 5/107: Measuring physical dimensions, e.g. size of the entire body or parts thereof
- G02C 2202/24: Myopia progression prevention
- G02C: SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES (trial frames for testing the eyes A61B3/04; goggles or eyeshields not having the same features as spectacles A61F9/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.

## Claims

### Claim at position 1

1-5. (canceled)

### Claim 6

A method, comprising:
forming an ophthalmic lens comprising an area having a plurality of elements selected from the group consisting of:
(i) bumps on a surface of the ophthalmic lens;
(ii) depressions on the surface of the ophthalmic lens;
(iii) translucent inclusions in a lens material; and
(iv) transparent inclusions in the lens material, the transparent inclusions having a refractive index different from that of the lens material,
wherein the elements are dot-shaped elements having, in the area of the ophthalmic lens, a non-zero dot density in a range between 0 and 8 dots per mm2.

### Claim 7 (depends on 6)

The method of claim 6, wherein the forming comprises obtaining an ophthalmic lens for a person identified as having an eye-lengthening disorder and introducing, to the area of the ophthalmic lens, the plurality of elements.

### Claim 8 (depends on 6)

The method of claim 6, wherein the non-zero dot density varies across the area.

### Claim 9 (depends on 8)

The method of claim 8, wherein the non-zero dot density increases in a radial direction from a central region of the ophthalmic lens toward a periphery of the ophthalmic lens.

### Claim 10 (depends on 6)

The method of claim 6, wherein the area continuously covers a central region of the ophthalmic lens.

### Claim 11 (depends on 10)

The method of claim 10, wherein the non-zero dot density varies across the area.

### Claim 12 (depends on 11)

The method of claim 11, wherein the non-zero dot density increases in a radial direction from the central region toward a periphery of the ophthalmic lens.

### Claim 13 (depends on 6)

The method of claim 6, wherein the area surrounds a second area left free of the elements.

### Claim 14 (depends on 13)

The method of claim 13, wherein the second area is located at a central region of the ophthalmic lens.

### Claim 15 (depends on 14)

The method of claim 14, wherein the second area has a diameter less than 10 mm.

### Claim 16 (depends on 6)

The method of claim 6, wherein the non-zero dot density varies across the area.

### Claim 17 (depends on 16)

The method of claim 16, wherein the non-zero dot density increases in a radial direction from a central region of the ophthalmic lens toward a periphery of the ophthalmic lens.

### Claim 18 (depends on 16)

The method of claim 16, wherein the area comprises a region in which the non-zero dot density is constant.

### Claim 19 (depends on 18)

The method of claim 18, wherein the region is in a peripheral region of the ophthalmic lens.

### Claim 20 (depends on 16)

The method of claim 16, wherein the ophthalmic lens comprises a central region, a peripheral region, and an intermediate region between the central region and the peripheral region, and
wherein the non-zero dot density radially varies in the intermediate region.

### Claim 21 (depends on 20)

The method of claim 20, wherein the non-zero dot density increases monotonically across the intermediate region from the central region to the peripheral region.

### Claim 22 (depends on 6)

The method of claim 6, wherein the plurality of elements consist entirely of bumps on a surface of the ophthalmic lens.

### Claim 23 (depends on 6)

The method of claim 6, wherein the plurality of elements have a density, dimension, and material selected to reduce a visual acuity in a patient's vision when looking through the area.

### Claim 24 (depends on 23)

The method of claim 23, wherein the density, dimension, and material of the plurality of elements in the area are selected to reduce a visual acuity from 20/20 when a line of sight of the patient looking through the first lens passes through the second area to about 20/25 when the line of sight the patient passes through the first area.

### Claim 25 (depends on 6)

The method of claim 6, further comprising providing a patient with eyeglasses containing the ophthalmic lens.
